Søgning
Søgning på udtrykket 'covid' giver 55 resultater
Dokumenter [9] Sider [3] Kalender [2] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [9]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Ændringer siden version 29: Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo.
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne.
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid.
Kalender [2]
2. april, Lille auditorium, Sjællands Universitets Sygehus
31. marts, Online
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
28.03.2025
by Esmaiel Maghsoodi, Edris Hasanpour, Farzaneh Soleimani, Moosa Aghal, Keyvan Mollarahimi .
PLoS One Infectious Diseases
28.03.2025
by Cleber Vinicius Brito dos Santos, Lara Esteves Coelho, Guilherme Tegoni Goedert, Paula Mendes Luz, Guilherme Loureiro Werneck, Daniel Antunes Maciel Villela, Cláudio José Struchiner . Background We quantified the national- and state-level burden of COVID-19 in Brazil and its states during 2020 and contrasted it to the burden from other causes of disease and injury. Methods We used national surveillance data on COVID-19 cases, hospitalisations and deaths between February/2020 to December/2020.
BMC Infectious Diseases
27.03.2025
. Background. This study included tuberculosis (TB) patients from high-burden Russian regions of Siberia and Far East. We aimed to assess the impact of the COVID-19 pandemic on the genotypic structure of Mycobacterium tuberculosis population and on epidemiology and clinical course of tuberculosis in TB and TB/COVID-19 coinfected patients. . Methods. A total of 456 M.
BMC Infectious Diseases
27.03.2025
…reats. Identification of simple factors for stratification and prognostics of hospitalized patients is crucial for management of these patients in limited resource settings. The aim of this study was to assess the biological profile of severe hospitalized COVID-19 patients in Cameroon and identify risk factors for mortality. . Methods.
BMC Infectious Diseases
27.03.2025
. Background. While children and adolescents typically experience mild symptoms during the acute phase of the COVID-19 infection, some may develop severe post-infectious symptoms. In our study Post-COVID Kids Bavaria we integrated somatic and psychiatric aspects of the post-COVID syndrome to provide a holistic description of symptoms, provide early treatment, and detect possible risk factors associated with post-infectious neurocognitive and emotional impairments.
Clinical Infectious Diseases
27.03.2025
PLoS One Infectious Diseases
27.03.2025
by Jie Liu, Kefan Zhou, Chen Meng, Zhuzhu Liu, Ruihua Huang, Yousuf Waheed, Fan Yang, Kun Liu, Jiaqi Zhao, Lin Zhang, Xiaoyan Yu, Shuang Li, Tianyu Li, Yanshan Tong, Xiaodan Wei, Chuankuo Tian, Dong Sun, Xinglei Zhou . Background. The COVID-19 pandemic has made treating renal anemia in chronic kidney disease (CKD) patients undergoing peritoneal dialysis (PD) difficult. The current study aims to compare roxadustat with erythropoiesis-stimulating agents (ESAs) during the COVID-19 pandemic. . Methods.
Malaria Journal
26.03.2025
… coinfection between SARS-CoV-2 and one of the famous vector-borne diseases, malaria, are crucial for disease control, especially in malaria-endemic areas. The clinical profiles, possible mechanisms for interactions, and representative control measures of COVID-19 and malaria coinfections have recently garnered public attention.
Infection
26.03.2025
. Purpose. To assess the impact of early sotrovimab treatment versus no treatment on the risk of developing post-acute sequelae of COVID-19 (PASC; long COVID) in patients (age ≥ 12 years) with COVID-19 at high risk for progression to severe disease. . Methods. Retrospective cohort study using the US National COVID Cohort Collaborative (N3C) data.
Infection
26.03.2025
. Purpose. To assess the incidence and clinical impact of CMV infection in critically ill COVID-19 patients, examining ICU and hospital mortality, and length of hospital stay. . Methods. In this single-center, prospective observational study (March 2020 - September 2022), 431 patients with COVID-19 pneumonia and moderate to severe ARDS were included.
Infection
26.03.2025
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe complication arising from the co-infection of viral and fungal pathogens in the lungs, with its incidence notably increasing. Although significant progress has been made in elucidating the pathogenesis of CAPA in recent years, the precise pathophysiological mechanisms underlying this condition remain only partially understood.
Journal of Infectious Diseases
26.03.2025
Abstract . Non-pharmaceutical interventions (NPIs) for COVID-19 resulted in the reduction of many viral diseases aside from SARS-CoV-2, but their impact on the US military or beneficiary population have not been assessed. Using TRICARE data (2016-2023), we modeled changes in acute gastroenteritis (AGE) and acute respiratory infection (ARI) encounters pre- and post-pandemic. In 2020, AGE and ARI encounters decreased substantially (RR = 0.50, 95% CI [0.31, 0.80]; RR = 0.60, [0.41, 0.88]).
BMJ Open
26.03.2025
…n among residents of long-term care (LTC). Despite depression being the most common type of mental illness, it is often undiagnosed in LTC. Due to its prevalence, chronicity and associated morbidity, depression poses a considerable service use burden. The COVID-19 pandemic has brought needed attention to the mental health challenges faced by older adults in LTC. . Objectives. To explore the effects of isolation on the mood of LTC residents and compare between both the pre-COVID-19 and COVID-19 periods. .
BMJ Open
26.03.2025
. Objectives. Vitamin D deficiency is prevalent among the population. Previous studies have shown that vitamin D supplementation might be useful for treating COVID-19 infection. Therefore, we performed a meta-analysis to explore vitamin D supplementation efficacy in treating COVID-19 patients with vitamin D deficiency. . Design. Systematic review and meta-analysis . Data sources. PubMed, Cochrane Library, Embase and Web of Science. . Eligibility criteria.
BMC Infectious Diseases
26.03.2025
. Background. While children and adolescents typically experience mild symptoms during the acute phase of the COVID-19 infection, some may develop severe post-infectious symptoms. In our study Post-COVID Kids Bavaria we integrated somatic and psychiatric aspects of the post-COVID syndrome to provide a holistic description of symptoms, provide early treatment, and detect possible risk factors associated with post-infectious neurocognitive and emotional impairments.
BMJ Open
25.03.2025
…its potential impact on the study pool as part of a research integrity assessment (RIA). . Design. Meta-epidemiological study. . Setting. Assessment of ethics approval; domain 3 of the RIA tool developed for evidence syntheses. . Participants/subjects. COVID-19 RCTs included in evidence syntheses. . Primary outcomes. We extracted ethical items from study reports, that is, ethics approval statements, EC details, ethics approval numbers (ENs), IC and verified national recognition of ECs.
BMC Infectious Diseases
25.03.2025
…and associated miRNAs in 88 hospitalized COVID-19 patients and 20 healthy controls, comparing the acute and post-acute phases to assess their impact on disease severity and recovery. Our findings revealed an association between reduced MAS1 expression in both advanced age (P = 0.03) and the need for oxygen supplementation (P = 0.04). Additionally, reduced ACE expression was associated with worse mortality outcomes (P = 0.01). Notably, ACE2 and TMPRSS2 expression was significantly decreased (P
BMC Infectious Diseases
25.03.2025
. Background. Identifying patients at a risk of severe COVID-19 is crucial for prompt intervention and mortality risk mitigation. The monocyte distribution width (MDW) is an effective accurate predictor of sepsis in emergency settings, facilitating timely patient management. However, few reliable laboratory parameters are available for predicting the severity and prognosis of COVID-19.
PLoS One Infectious Diseases
25.03.2025
…ching implications for educational outcomes at the tertiary level. Teachers contribute to students’ success in various ways, including academic support, career counseling, personal mentoring, etc., that help them succeed academically and professionally. COVID-19 disrupted teacher-student interaction and hindered the flow of teacher’s support to students. The damage caused by the pandemic to the higher education sector has mostly recovered.
BMJ Open
23.03.2025
. Objectives. To examine the effectiveness of exercise interventions to improve long COVID symptoms and the tolerance of exercise interventions among people with long COVID. . Design. Systematic review. . Data sources. Medline via EBSCOhost, Embase via OVID and CENTRAL via the Cochrane Library up to 28 February 2023. . Eligibility criteria for selecting studies.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Morbidity and Mortality Weekly Report (MMWR)
27.03.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ECDC COVID-19 updates
26.03.2025
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
26.03.2025
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
ECDC COVID-19 updates
22.03.2025
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
Medscape Infectious Diseases
19.03.2025
After COVID-19, RSV cases appear earlier and result in more severe illness in infants, with increased oxygen and ventilation needs, a new study reports. . Medscape News UK
Medscape Infectious Diseases
14.03.2025
Daily oral drug reduced COVID-19 risk by 67% in exposed but uninfected adults . Medscape Medical News
Medscape Infectious Diseases
14.03.2025
Measles cases in the European region doubled in 2024 to a more than 25-year-high, the World Health Organisation and UNICEF said on Thursday, as they urged action to restore. . Reuters Health Information
Eurosurveillance latest updates
14.03.2025
. Background. Evolution of SARS-CoV-2 is continuous. . . Aim. Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity. . . Methods. In nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined.
Medscape Infectious Diseases
14.03.2025
Germany's foreign intelligence service in 2020 put at 80%-90% the likelihood that the coronavirus behind the COVID-19 pandemic was accidentally released from China's Wuhan. . Reuters Health Information
Medscape Infectious Diseases
13.03.2025
The study quantifies the direct and indirect harms to life caused by the pandemic. . Medscape Medical News
Medscape Infectious Diseases
13.03.2025
Vaccinated persons had fewer emergency medical visits than those who were not vaccinated. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
12.03.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Medscape Infectious Diseases
12.03.2025
Adjusted odds ratio showed similar prevalence of long COVID in cancer survivors and controls. . Medscape Medical News
ECDC COVID-19 updates
11.03.2025
This protocol presents an updated common methodology for estimating COVID-19 vaccine effectiveness (VE) using established health data registries in participating European Union (EU) and European Economic Area (EEA) Member States.
Medscape Infectious Diseases
11.03.2025
Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised patients with mild COVID-19. . Medscape News UK
ProMED
9.03.2025
…********************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . In this update: . [1] Selected regions . [A] Hong Kong: JN.1 COVID-19 vaccine to replace the XBB vaccine for. infants and children . [B] New Zealand (Tairāwhiti/Gisborne): First COVID-19 death of 2025. recorded . [2] Another bat virus discovered from China: What makes HKU5-CoV-2. different from COVID-19 .
Medscape Infectious Diseases
8.03.2025
OUD treatment in opioid treatment programs is associated with a lower risk for COVID-19 diagnoses and COVID-related emergency department visits than other treatment approaches or no treatment. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
28.02.2025
This report describes 2024-2025 COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care encounters.
Eurosurveillance latest updates
28.02.2025
. Background. During the first year of the COVID-19 pandemic, vaccination programmes targeted children and adolescents to prevent severe outcomes of SARS-CoV-2 infection. . . Aim. To estimate COVID-19 vaccine effectiveness (VE) against hospitalisation due to COVID-19 in the paediatric population, among those with and without previously documented SARS-CoV-2 infection. . . Methods.
ECDC COVID-19 updates
28.02.2025
This report presents a description of COVID-19 vaccine coverage in the EU/EEA between 1 August 2024 and 17 January 2025, with some variation in dates between countries.